MedTrace Logo

Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia

NCT02074943 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-12-11

No results posted yet for this study

Summary

The investigators plan to conduct a clinical trial to assess the effects and safety of platelet rich plasma on androgenetic alopecia.

Conditions

Interventions

BIOLOGICAL

PRP

PRP will be inject to half head. The other half will be injected with normal saline.

Sponsors & Collaborators

  • Vancouver General Hospital

    lead OTHER

Principal Investigators

  • Jerry Shapiro, MD · Professor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-06-30
Completion
2015-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02074943 on ClinicalTrials.gov